Yousif Capital Management, LLC Seagen Inc. Transaction History

Yousif Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 30, 2023	BUY	$191.51 - $216.16 $10,533 - $11,888	55 Added 3.49%	1,632 $346,000
Q2 2023 Aug 02, 2023	SELL	$187.64 - $206.25 $2,064 - $2,268	-11 Reduced 0.69%	1,577 $303,000
Q1 2023 May 02, 2023	BUY	$127.59 - $203.08 $202,612 - $322,491	1,588 New	1,588 $321,000
Q2 2022 Aug 01, 2022	SELL	$108.81 - $179.33 $62,021 - $102,218	-570 Reduced 28.47%	1,432 $253,000
Q1 2022 May 12, 2022	BUY	$119.61 - $157.85 $13,157 - $17,363	110 Added 5.81%	2,002 $288,000

Q4 2021 Jan 31, 2022	BUY	$142.57 - $190.86 $269,742 - $361,107	1,892 New	1,892 $293,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Yousif Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Yousif Capital Management, LLC with notifications on news.